Thouvenin, J.; Masson, C.; Boudier, P.; Maillet, D.; Kuchler-Bopp, S.; Barthélémy, P.; Massfelder, T.
Complete Response in Metastatic Clear Cell Renal Cell Carcinoma Patients Treated with Immune-Checkpoint Inhibitors: Remission or Healing? How to Improve Patients’ Outcomes? Cancers 2023, 15, 793.
https://doi.org/10.3390/cancers15030793
AMA Style
Thouvenin J, Masson C, Boudier P, Maillet D, Kuchler-Bopp S, Barthélémy P, Massfelder T.
Complete Response in Metastatic Clear Cell Renal Cell Carcinoma Patients Treated with Immune-Checkpoint Inhibitors: Remission or Healing? How to Improve Patients’ Outcomes? Cancers. 2023; 15(3):793.
https://doi.org/10.3390/cancers15030793
Chicago/Turabian Style
Thouvenin, Jonathan, Claire Masson, Philippe Boudier, Denis Maillet, Sabine Kuchler-Bopp, Philippe Barthélémy, and Thierry Massfelder.
2023. "Complete Response in Metastatic Clear Cell Renal Cell Carcinoma Patients Treated with Immune-Checkpoint Inhibitors: Remission or Healing? How to Improve Patients’ Outcomes?" Cancers 15, no. 3: 793.
https://doi.org/10.3390/cancers15030793
APA Style
Thouvenin, J., Masson, C., Boudier, P., Maillet, D., Kuchler-Bopp, S., Barthélémy, P., & Massfelder, T.
(2023). Complete Response in Metastatic Clear Cell Renal Cell Carcinoma Patients Treated with Immune-Checkpoint Inhibitors: Remission or Healing? How to Improve Patients’ Outcomes? Cancers, 15(3), 793.
https://doi.org/10.3390/cancers15030793